Acquired Immunity Trumps ypN+ and TRG as the Sole Prognostic Biomarker for Locally Advanced Rectal Cancer (LARC) Treated With Neoadjuvant Chemoradiation Therapy (NeoCRT)
Acquired Immunity Trumps ypN+ and TRG as the Sole Prognostic Biomarker for Locally Advanced Rectal Cancer (LARC) Treated With Neoadjuvant Chemoradiation Therapy (NeoCRT)
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation